Related Experiment Video
Updated: Feb 25, 2026

09:37
Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
Published on: August 15, 2014
45.0K
Structural insights into a high affinity nanobody:antigen complex by homology modelling.
1Department of Clinical Biochemistry, Copenhagen University Hospital, Kettegård Alle 30, DK-2650 Hvidovre, Denmark.
Journal of Molecular Graphics & Modelling
|August 6, 2017
Summary
Porphyromonas gingivalis detection is simplified by a novel nanobody assay targeting the RgpB protease. This study models the VHH7 nanobody and its RgpB binding site, aiding future diagnostic tool development.
Area of Science:
- Oral microbiology
- Immunology
- Structural biology
Background:
- Porphyromonas gingivalis is a key pathogen in periodontitis.
- The cysteine protease RgpB, secreted by P. gingivalis, is a potential diagnostic target.
- A nanobody, VHH7, exhibits high affinity and specificity for RgpB.
Purpose of the Study:
- To build a homology model of the VHH7 nanobody.
- To identify key residues involved in the VHH7-RgpB interaction.
- To provide insights for developing targeted RgpB therapies.
Main Methods:
- Homology modeling of VHH7 nanobody.
- Identification of complementarity determining regions (CDRs) and RgpB epitope residues.
- Information-driven flexible docking using the HADDOCK server.
Main Results:
- The VHH7 homology model and VHH7:RgpB complex were analyzed.
- The RgpB epitope was located within its immunoglobulin-like domain.
- Key residue pairs at the paratope:epitope interface crucial for complex stability were identified.
Conclusions:
- The study provides structural insights into the VHH7-RgpB interaction.
- This knowledge can guide the design of specific RgpB-targeting antibody-drug conjugates.
- The findings support RgpB as a viable target for Porphyromonas gingivalis diagnostics and therapeutics.
More Related Videos
Related Concept Videos
Antibody Structure
66.0K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
66.0K
Antibody Actions
3.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.1K
Antibody Structure and Classes
9.6K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
9.6K

